Age-related guideline adherence and outcome in low rectal cancer

Diseases of the Colon and Rectum

Volumn 57, Issue 8, 2014, Pages 967-975

  Schiphorst, Anandi H W ^a   Verweij, Norbert M ^a   Pronk, Apollo ^a   Hamaker, Marije E ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Elderly; Guideline adherence; Rectal cancer; TME; Treatment decisions

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPLICATION; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; LOW RECTAL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECTUM CANCER; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; COMORBIDITY; DECISION MAKING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RECTAL NEOPLASMS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84904913442     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000145     Document Type: Article

References (40)

1. Cifers Over Kanker. Nederlandse Kankerregistratie. www.cijfersoverkanker. nl. Accessed December 1, 2013.
2. van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg. 2010;97: 383-390.
3. Yeo HL, Paty PB. Management of recurrent rectal cancer: practical insights in planning and surgical intervention. J Surg Oncol. 2014;109: 47-52.
4. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345: 638-646.
5. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133: 894-899. (Pubitemid 28374285)
6. Shearer R, Gale M, Aly OE, Aly EH. Have early postoperative complications from laparoscopic rectal cancer surgery improved over the past 20 years? Colorectal Dis. 2013;15: 1211-1226.
7. Schiphorst AH, Doeksen A, Hamaker ME, Zimmerman DD, Pronk A. Short-term follow-up after laparoscopic versus conventional total mesorectal excision for low rectal cancer in a large teaching hospital. Int J Colorectal Dis. 2014;29: 117-125.
8. Breukink S, Pierie J, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2006;(4): CD005200.
9. Collinson FJ, Jayne DG, Pigazzi A, et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis. 2012;27: 233-241.
10. Huibers CJ, de Roos MA, Ong KH. The effect of the introduction of the ERAS protocol in laparoscopic total mesorectal excision for rectal cancer. Int J Colorectal Dis. 2012;27: 751-757.
11. Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev. 2011;(2): CD007635.
12. Extermann M, Aapro M, Bernabei R, et al.; Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55: 241-252. (Pubitemid 41219694)
13. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341: 2061-2067. (Pubitemid 30035956)
14. Maas HA, Lemmens VE, Nijhuis PH, de Hingh IH, Koning CC, Janssen-Heijnen ML. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older. Eur J Surg Oncol. 2013;39: 1087-1093.
15. Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a populationbased study. Eur J Cancer. 2006;42: 3015-3021. (Pubitemid 44667466)
16. Dekker JW, van den Broek CB, Bastiaannet E, van de Geest LG, Tollenaar RA, Liefers GJ. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol. 2011;18: 1533-1539.
17. Cameron MG, Kersten C, Vistad I, Fosså S, Guren MG. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer: a systematic review. Acta Oncol. 2014;53: 164-173.
18. Akiyoshi T, Kuroyanagi H, Oya M, et al. Short-term outcomes of laparoscopic rectal surgery for primary rectal cancer in elderly patients: is it safe and beneficial? J Gastrointest Surg. 2009;13: 1614-1618.
19. Manceau G, Karoui M, Werner A, Mortensen NJ, Hannoun L. Comparative outcomes of rectal cancer surgery between elderly and non-elderly patients: a systematic review. Lancet Oncol. 2012;13: e525-e536.
20. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246: 215-221. (Pubitemid 47196518)
21. Endreseth BH, Romundstad P, Myrvold HE, Bjerkeset T, Wibe A; Norwegian Rectal Cancer Group. Rectal cancer treatment of the elderly. Colorectal Dis. 2006;8: 471-479. (Pubitemid 43834449)
22. Jung B, Påhlman L, Johansson R, Nilsson E. Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer. 2009;9: 68.
23. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 2008;9: 494-501. (Pubitemid 351626863)
24. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21: 1383-1389. (Pubitemid 46606420)
25. Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol. 2005;23: 3112-3124. (Pubitemid 46224135)
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373-383. (Pubitemid 17055592)
27. Oncoline. Rectumcarcinoom. www.oncoline.nl/rectumcarcinoom. Accessed December 1, 2013.
28. van der Pas MH, Haglind E, Cuesta MA, et al.; COlorectal cancer Laparoscopic or Open Resection II (COLO R II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLO R II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14: 210-218.
29. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92: 615-623. (Pubitemid 40685658)
30. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Longterm results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008;(2): CD003432.
31. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASI CC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97: 1638-1645.
32. Barrier A, Ferro L, Houry S, Lacaine F, Huguier M. Rectal cancer surgery in patients more than 80 years of age. Am J Surg. 2003;185: 54-57. (Pubitemid 36071649)
33. Damhuis RA, Wereldsma JC, Wiggers T. The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer. Int J Colorectal Dis. 1996;11: 45-48. (Pubitemid 26046228)
34. Mahoney T, Kuo YH, Topilow A, Davis JM. Stage II colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg. 2000;135: 182-185. (Pubitemid 30078472)
35. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20: 1192-1202. (Pubitemid 34177424)
36. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage II colon cancer. J Natl Cancer Inst. 2001;93: 850-857. (Pubitemid 32590779)
37. Decoster L, Kenis C, Van Puyvelde K, et al. The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer. J Geriatr Oncol. 2013;4: 235-241.
38. Kenis C, Bron D, Libert Y, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol. 2013;24: 1306-1312.
39. Hamaker ME, Schiphorst AH, Ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a geriatric evaluation on treatment decisions for older cancer patients: a systematic review. Acta Oncol. 2014;53: 289-296.
40. Wedding U, Roehrig B, Klippstein A, et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol. 2007;61: 269-276. (Pubitemid 46329431)